Human Papillomavirus (HPV) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Study of HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HNSCC)
Conditions: HPV16+ Squamous Cell Carcinoma Interventions: Drug: HB-200; Other: Placebo Sponsors: Memorial Sloan Kettering Cancer Center; Hookipa Biotech GmbH; Naveris Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials

Conversational Agents to Improve HPV Vaccine Acceptance in Primary Care (ECA-HPV) Clinical Trial
Conditions: Human Papilloma Virus Interventions: Behavioral: Usual Care; Behavioral: ECA-HPV App with Clinic Notification and Adolescent Functions Disabled; Behavioral: ECA-HPV App with Clinic Notification Function Enabled; Behavioral: ECA-HPV App with Adolescent Function Enabled; Behavioral: ECA-HPV App with Clinic Notification and Adolescent Functions Enabled Sponsors: Tufts Medical Center; Boston Medical Center; Northeastern University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials

Saliva Testing for High-Risk Human Papillomavirus Infection Oral Cavity and Pharynx Cancer
Conditions: Oropharyngeal Squamous Cell Carcinoma; Human Papillomavirus Infection Interventions: Genetic: Pre-Radiation Dental Evaluation/Sample Collection; Other: Pre-Study Visit; Genetic: Oral Medicine Consultation Visit/Sample Collection Sponsors: Wake Forest University Health Sciences; InnoTech Precision Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials

Communicating Human Papillomavirus Vaccine With Japanese Parents and Caregivers With Daughters Aged 12-18
Conditions: Healthy Interventions: Behavioral: Group 1 (I x S x S x F); Behavioral: Group 2 (O x S x S x F); Behavioral: Group 3 (I x E x S x F); Behavioral: Group 4 (O x E x S x F); Behavioral: Group 5 (I x S x S x M); Behavioral: Group 6 (O x S x S x M); Behavioral: Group 7 (I x E x S x M); Behavioral: Group 8 (O x E x S x M); Behavioral: Group 9 (I x S x D x F); Behavioral: Group 10 (O x S x D x F); Behavioral: Group 11 (I x E x D x F); Behavioral: Group 12 (O x E x D x F); Behavioral: Group 13 (I x S x D x M); Behavioral: Group 14 (O x S x D x M); Behavioral: Group 15 (I x E x D x M); Behavioral: Group 16 (O x E x D x ...
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials

Immunogenicity and Safety of One Dose of HPV Vaccine
Conditions: Human Papillomavirus Vaccines Interventions: Biological: HPV vaccine Sponsors: Xiamen Innovax Biotech Co., Ltd Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials

Vaginal Self-sampling for Detecting High-risk Human Papillomavirus Cervical Infection in Patients With Immune-mediated Inflammatory Diseases
Conditions: HPV Infection; Systemic Disease Interventions: Procedure: Vaginal self sampling detecting HPV Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials

Clinical Study to Evaluate SIIPL qHPV Vaccine (CERVAVAC ®) in Women Living With HIV Aged 15-25 Years
Conditions: Human Papillomavirus Infection Interventions: Biological: Cervavac as three dose regimen; Biological: Cervavac as two dose regimen; Biological: Gardasil as three dose regimen Sponsors: Serum Institute of India Pvt. Ltd.; Bill and Melinda Gates Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials

A Study in Subjects With Human Papillomavirus 16 or 18 Associated Cervical Intraepithelial Neoplasia Grade 2 or 3
Conditions: Human Papillomavirus Associated Intraepithelial Neoplasia; Cervical Intraepithelial Neoplasia Grade 2/3; Human Papillomavirus Type 16 Infection; Human Papillomavirus Type 18 Infection Interventions: Biological: RG002 injection Sponsors: RinuaGene Biotechnology Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials

The Adjuvant Effect of HPV Vaccination on Recurrence of Cervical Precancer or Car-cinoma in Women Undergoing Conization
Conditions: Cervical Intraepithelial Neoplasia Grade 2/3; Recurrence Interventions: Biological: vaccination against human papillomavirus infection (HPV vaccination) Sponsors: Charles University, Czech Republic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials

The Adjuvant Effect of HPV Vaccination on Recurrence of Cervical Precancer or Carcinoma in Women Undergoing Conization
Conditions: Cervical Intraepithelial Neoplasia Grade 2/3; Recurrence Interventions: Biological: vaccination against human papillomavirus infection (HPV vaccination) Sponsors: Charles University, Czech Republic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials

Prevalence of HPV (Human Papilloma Virus) and HPV Vaccination Among Victims of Sexual Violence
Conditions: Human Papilloma Virus; Sexual Assault; Sex Abuse Interventions: Diagnostic Test: smears Sponsors: Centre Hospitalier Universitaire Saint Pierre; Merck Sharp& Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials

Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary Care
Conditions: Human Papillomavirus Infection Interventions: Other: Educational Intervention Sponsors: Roswell Park Cancer Institute; National Cancer Institute (NCI); National Institute on Minority Health and Health Disparities (NIMHD) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials

Evaluation of First-void Urine as an Alternative to Cervical Sampling for Human Papillomavirus (HPV) Testing in Cervical Cancer Screening (Single-center Study).
Conditions: Uterine Cervical Cancer Interventions: Other: Urine sample, 1st stream; Other: Cervico-vaginal swab Sponsors: Centre Hospitalier Universitaire de Saint Etienne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials

Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma
Conditions: Oropharynx Cancer, Stage I Interventions: Biological: Atezolizumab; Procedure: Transoral Surgery with cervical lymphadenctomy (neck dissection); Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging Sponsors: Emory University; National Cancer Institute (NCI); Genentech, Inc. Suspended (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials

Probiotc Lactobacillus Crispatus-M247 (Crispact ®) Supplementation in the Sterilization of High-risk Human Papilloma (HPV-HR) Viruses
Conditions: Human Papillomavirus Infection Interventions: Dietary Supplement: Crispact ®; Dietary Supplement: Placebo Sponsors: Liaquat University of Medical& Health Sciences; Universit à degli Studi dell ' Insubria Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials